Hemodynamic and hormonal effects of exogenous adrenomedullin administration in humans and relationship to insulin resistance

Hypertension Research

Volumn 33, Issue 4, 2010, Pages 314-319

  Kita, Toshihiro ^a   Suzuki, Yoshihiko ^a,b   Kitamura, Kazuo ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b Suzuki Clinic   (Japan)

Author keywords

Adrenomedullin; Insulin resistance; Nicardipine; Pulse wave velocity

Indexed keywords

ADRENOMEDULLIN; NICARDIPINE; NORADRENALIN; RENIN;

ARTERIAL STIFFNESS; ARTICLE; BLOOD FLOW; BODY MASS; CLINICAL ARTICLE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HOMEOSTASIS; HUMAN; HYPERTENSION; HYPOTENSION; INSULIN RESISTANCE; PULSE WAVE; SYSTOLIC BLOOD PRESSURE;

ADRENOMEDULLIN; ADULT; ARTERIES; COMPLIANCE; HEMODYNAMICS; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; VASODILATOR AGENTS;

EID: 77950492890     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.236     Document Type: Article

References (29)

1. Eto T, Kato J, Kitamura K. Regulation of production and secretion of adrenomedullin in the cardiovascular system. Regl Pept 2002; 112: 61-69.
2. Elsasser TH, Kahl S. Adrenomedullin has multiple roles in disease stress: development and remission of the inflammatory response. Microsc Res Tech 2002; 57: 120-129. (Pubitemid 34438618)
3. Wong LY, Cheung BM, Li Y-Y, Tang F. Adrenomedullin is both proinflammatory and anti-inflammatory: its effects on gene expression and secretion of cytokines and macrophage migration inhibitory factor in NR8383 macrophage cell line. Endocrinology 2005; 146: 1321-1327.
4. Shimosawa T, Shibagaki Y, Ishibashi K, Kitamura K, Kangawa K, Kato S, Ando K, Fujita T. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 2002; 105: 106-111.
5. Marutsuka K, Hatakeyama K, Sato Y, Yamashita A, Sumiyoshi A, Asada Y. Immunohis-tological localization and possible functions of adrenomedullin. Hypertens Res 2003; 26 (Suppl): S33-S40.
6. Shinomiya K, Ohmori K, Ohyama H, Hosomi N, Takahashi T, Osaka K, Kohno M. Association of plasma adrenomedullin with carotid atherosclerosis in chronic ischemic stroke. Peptides 2001; 22: 1873-1880.
7. Kita T, Kitamura K, Hashida S, Morishita K, Eto T. Plasma adrenomedullin is closely correlated with pulse wave velocity in middle-aged and elderly patients. Hypertens Res 2003; 26: 887-893.
8. Shimosawa T, Ogihara T, Matsui H, Asano T, Ando K, Fujita T. Deficiency of adreno-medullin induces insulin resistance by increasing oxidative stress. Hypertension 2003; 41: 1080-1085.
9. Xing G, Shimosawa T, Ogihara T, Matsui H, Itakura K, Qingyou X, Asano T, Ando K, Fujita T. Angiotensin II-induced insulin resistance is enhanced in adrenomedullin-deficient mice. Endocrinology 2004; 145: 3647-3651.
10. Lainchbury JG, Troughton RW, Lewis LK, Yandle TG, Richards AM, Nicholls MG. Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers. J Clin Endocrinol Metab 2000; 85: 1016-1020.
11. Troughton RW, Levis LK, Yandle TG, Richards AM, Nicholls MG. Hemodynamic, hormone, and urinary effects of adrenomedullin infusion in essential hypertension. Hypertension 2000; 36: 588-593.
12. Nagaya N, Satoh T, Nishikimi T, Uematsu M, Furuichi S, Sakamaki F, Oya H, Kyotani S, Nakanishi N, Goto Y, Masuda Y, Miyatake K, Kangawa K. Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 2000; 101: 498-503.
13. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 32: 570-574.
14. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
15. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103: 987-992.
16. Blankenhorn DH, Chin HP, Conover DJ, Nessim SA. Ultrasound observation on pulsation in human carotid artery lesions. Ultrasound Med Biol 1988; 14: 583-587.
17. Owji AA, Smith DM, Coppock HA, Morgan DG, Bhogal R, Ghatel MA, Bloom SR. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology 1995; 136: 2127-2134.
18. Ihara T, Ikeda U, Tate Y, Ishibashi S, Shimada K. Positive inotropic effects of adrenomedullin on rat papillary muscle. Eur J Pharmacol 2000; 390: 167-172.
19. Luodonpää M, Leskinen H, Ilves M, Vuolteenaho O, Ruskoaho H. Adrenomedullin modulates hemodynamic and cardiac effects of angiotensin II in conscious rats. Am J Physiol 2004; 286: R1085-R1092.
20. Szokodi I, Kinnunen P, Tavi P, Weckstrom M, Toth M, Ruskoaho H. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation 1998; 97: 1062-1070.
21. Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, Chikamori T, Hori S, Yamamoto Y, Doba N, Hinohara S. Influences of age and gender on results of noninvasive brachialankle pulse wave velocity measurement\a survey of 12517 subjects. Atherosclerosis 2003; 166: 303-309.
22. Yamashina A, Tomiyama H, Arai T, Hirose H, Koji Y, Hirayama Y, Yamamoto Y, Hori S. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003; 26: 615-622.
23. Kitahara T, Ono K, Tsuchida A, Kawai H, Shinohara M, Ishii Y, Koyanagi H, Noguchi T, Matsumoto T, Sekihara T, Watanabe Y, Kanai H, Ishida H, Nojima Y. Impact of brachial-ankle pulse wave velocity and ankle-brachial blood pressure index on mortality in hemodialysis patients. Am J Kidney Dis 2005; 46: 688-696.
24. Munakata M, Nagasaki A, Nunokawa T, Sakuma T, Kato H, Yoshinaga K, Toyota T. Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients. Am J Hypertens 2004; 17: 1050-1055.
25. Ghiadoni L, Penno G, Giannarelli C, Plantinga Y, Bernardini M, Pucci L, Miccoli R, Taddei S, Salvetti A, Del Prato S. Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus. Hypertension 2008; 51: 440-445.
26. Kovaite M, Petrulioniene Z, Ryliskyte L, Badariene J, Dzenkeviciute V, Cypiene A, Laucevicius A, Polena S, Gintautas J. Systemic assessment of arterial wall structure and function in metabolic syndrome. Proc West Pharmacol Soc 2007; 50: 123-130.
27. El Feghali R, Topouchian J, Pannier B, Asmar R. Ageing and blood pressure modulate the relationship between metabolic syndrome and aortic stiffness in never-treated essential hypertensive patients. A comparative study. Diabetes Metab 2007; 33: 183-188.
28. Lim SC, Morgenthaler NG, Subramanian T, Wu YS, Goh SK, Sum CF. The relationship between adrenomedullin, metabolic factors, and vascular function in individuals with type 2 diabetes. Diabetes Care 2007; 30: 1513-1519.
29. Nishikimi T. Adrenomedullin in cardiovascular disease. Adv Pharmacol 1998; 42: 599-603.